| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.972 | 0.001 | 0.972 | NMDA receptor glycine site antagonist | 0.952 0.001 DBMET01818 | ||
| 0.933 | 0.002 | 0.956 | NMDA receptor antagonist | 0.956 0.002 DBMET01818 | DBMET01818 | |
| 0.922 | 0.001 | 0.922 | NMDA receptor agonist | 0.869 0.001 DBMET01818 | ||
| 0.89 | 0.001 | 0.89 | NMDA receptor glycine site agonist | 0.81 0.001 DBMET01818 | ||
| 0.698 | 0.002 | 0.761 | NMDA receptor subunit 3A antagonist | 0.761 0.002 DBMET01818 | DBMET01818 | |
| 0.686 | 0.004 | 0.686 | Glutamate receptor antagonist | 0.646 0.004 DBMET01818 | ||
| 0.666 | 0.002 | 0.75 | NMDA receptor subunit 3B antagonist | 0.75 0.002 DBMET01818 | DBMET01818 | |
| 0.502 | 0.028 | 0.527 | Histamine release inhibitor | 0.527 0.021 DBMET01818 | DBMET01818 | |
| 0.466 | 0.045 | 0.474 | 5 Hydroxytryptamine release inhibitor | 0.474 0.041 DBMET01818 | DBMET01818 | |
| 0.41 | 0.003 | 0.497 | NMDA 2A receptor antagonist | 0.497 0.003 DBMET01818 | DBMET01818 | |
| 0.407 | 0.004 | 0.546 | NMDA 2 receptor antagonist | 0.546 0.004 DBMET01818 | DBMET01818 | |
| 0.385 | 0.024 | 0.385 | Anticonvulsant | 0.228 0.066 DBMET01818 | ||
| 0.358 | 0.003 | 0.358 | Kainate receptor antagonist | 0.293 0.003 DBMET01818 | ||
| 0.374 | 0.047 | 0.479 | 12-Lipoxygenase inhibitor | 0.479 0.024 DBMET01818 | DBMET01818 | |
| 0.34 | 0.017 | 0.35 | Mcl-1 antagonist | 0.35 0.015 DBMET01818 | DBMET01818 | |
| 0.283 | 0.002 | 0.283 | Kainate receptor 1 antagonist | 0.197 0.003 DBMET01818 | ||
| 0.282 | 0.014 | 0.282 | Succinate dehydrogenase inhibitor | 0.273 0.016 DBMET01818 | ||
| 0.258 | 0.004 | 0.258 | Phosphorylase inhibitor | 0.244 0.004 DBMET01818 | ||
| 0.257 | 0.003 | 0.257 | Glycine receptor antagonist | 0.209 0.003 DBMET01818 | ||
| 0.35 | 0.099 | 0.445 | 15-Lipoxygenase inhibitor | 0.445 0.056 DBMET01818 | DBMET01818 | |
| 0.273 | 0.036 | 0.273 | Neuropeptide Y2 antagonist | 0.273 0.036 DBMET01818 | ||
| 0.241 | 0.004 | 0.279 | NMDA 2C receptor antagonist | 0.279 0.004 DBMET01818 | DBMET01818 | |
| 0.277 | 0.056 | 0.277 | Hypolipemic | 0.268 0.06 DBMET01818 | ||
| 0.257 | 0.067 | 0.266 | 5 Hydroxytryptamine 1E antagonist | 0.266 0.058 DBMET01818 | DBMET01818 | |
| 0.228 | 0.038 | 0.228 | 3C-like protease (Human coronavirus) inhibitor | 0.191 0.057 DBMET01818 | ||
| 0.25 | 0.06 | 0.25 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.227 0.073 DBMET01818 | ||
| 0.203 | 0.014 | 0.249 | Potassium channel (Ca-activated) activator | 0.249 0.008 DBMET01818 | DBMET01818 | |
| 0.319 | 0.159 | 0.377 | Apoptosis agonist | 0.377 0.125 DBMET01818 | DBMET01818 | |
| 0.195 | 0.036 | 0.207 | Catenin beta inhibitor | 0.207 0.027 DBMET01818 | DBMET01818 | |
| 0.222 | 0.069 | 0.229 | ErbB-1 antagonist | 0.229 0.064 DBMET01818 | DBMET01818 | |
| 0.153 | 0.008 | 0.153 | Prostaglandin E2 antagonist | 0.109 0.013 DBMET01818 | ||
| 0.147 | 0.004 | 0.147 | AMPA 1 receptor antagonist | 0.124 0.005 DBMET01818 | ||
| 0.241 | 0.106 | 0.325 | Lipoxygenase inhibitor | 0.325 0.06 DBMET01818 | DBMET01818 | |
| 0.22 | 0.092 | 0.23 | Aryl hydrocarbon receptor agonist | 0.23 0.087 DBMET01818 | DBMET01818 | |
| 0.21 | 0.087 | 0.221 | Peptidyltransferase inhibitor | 0.221 0.075 DBMET01818 | DBMET01818 | |
| 0.158 | 0.035 | 0.158 | Ferrochelatase inhibitor | |||
| 0.154 | 0.037 | 0.164 | Heat shock protein 70 antagonist | 0.164 0.023 DBMET01818 | DBMET01818 | |
| 0.273 | 0.156 | 0.315 | Antibacterial | 0.315 0.124 DBMET01818 | DBMET01818 | |
| 0.175 | 0.064 | 0.176 | ATPase inhibitor | 0.176 0.062 DBMET01818 | DBMET01818 | |
| 0.121 | 0.014 | 0.121 | Prostaglandin EP2 antagonist | 0.107 0.017 DBMET01818 | ||
| 0.143 | 0.04 | 0.143 | Sphingosine 1-phosphate receptor 4 antagonist | 0.124 0.066 DBMET01818 | ||
| 0.182 | 0.079 | 0.215 | DNA methyltransferase I inhibitor | 0.215 0.062 DBMET01818 | DBMET01818 | |
| 0.111 | 0.009 | 0.111 | Dihydroorotate dehydrogenase inhibitor | 0.103 0.01 DBMET01818 | ||
| 0.17 | 0.068 | 0.174 | Death-associated protein kinase 2 inhibitor | 0.174 0.062 DBMET01818 | DBMET01818 | |
| 0.111 | 0.01 | 0.111 | AMPA receptor antagonist | 0.09 0.014 DBMET01818 | ||
| 0.212 | 0.121 | 0.24 | Transcription factor STAT inhibitor | 0.24 0.094 DBMET01818 | DBMET01818 | |
| 0.095 | 0.005 | 0.095 | Kainate receptor 2 antagonist | 0.059 0.012 DBMET01818 | ||
| 0.182 | 0.092 | 0.182 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.168 0.106 DBMET01818 | ||
| 0.106 | 0.021 | 0.124 | Potassium channel large-conductance Ca-activated activator | 0.124 0.016 DBMET01818 | DBMET01818 | |
| 0.203 | 0.118 | 0.203 | Interleukin agonist | 0.18 0.139 DBMET01818 | ||
| 0.089 | 0.007 | 0.089 | Dihydroorotate oxidase inhibitor | 0.088 0.007 DBMET01818 | ||
| 0.205 | 0.127 | 0.228 | Transcription factor STAT3 inhibitor | 0.228 0.104 DBMET01818 | DBMET01818 | |
| 0.103 | 0.025 | 0.103 | Prostaglandin-E synthase inhibitor | 0.089 0.033 DBMET01818 | ||
| 0.081 | 0.006 | 0.081 | Heparanase inhibitor | 0.077 0.008 DBMET01818 | ||
| 0.098 | 0.023 | 0.105 | Leukotriene antagonist | 0.105 0.02 DBMET01818 | DBMET01818 | |
| 0.223 | 0.152 | 0.242 | Interleukin 2 agonist | 0.242 0.128 DBMET01818 | DBMET01818 | |
| 0.105 | 0.034 | 0.105 | Glutamate receptor agonist | |||
| 0.216 | 0.151 | 0.25 | Cholesterol antagonist | 0.25 0.125 DBMET01818 | DBMET01818 | |
| 0.108 | 0.047 | 0.108 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.083 0.077 DBMET01818 | ||
| 0.066 | 0.005 | 0.066 | Factor XI inhibitor | 0.051 0.01 DBMET01818 | ||
| 0.065 | 0.011 | 0.065 | Factor XIa inhibitor | 0.049 0.02 DBMET01818 | ||
| 0.067 | 0.014 | 0.067 | Fructose-1,6-bisphosphatase inhibitor | 0.055 0.02 DBMET01818 | ||
| 0.088 | 0.037 | 0.097 | GABA aminotransferase inhibitor | 0.097 0.029 DBMET01818 | DBMET01818 | |
| 0.062 | 0.011 | 0.072 | Nicotinic acid receptor agonist | 0.072 0.008 DBMET01818 | DBMET01818 | |
| 0.253 | 0.202 | 0.328 | Calcium channel L-type activator | 0.328 0.134 DBMET01818 | DBMET01818 | |
| 0.073 | 0.022 | 0.073 | Botulinum neurotoxin type A inhibitor | 0.072 0.023 DBMET01818 | ||
| 0.076 | 0.026 | 0.076 | MDM2 inhibitor | |||
| 0.139 | 0.091 | 0.156 | Protein-tyrosine phosphatase inhibitor | 0.156 0.072 DBMET01818 | DBMET01818 | |
| 0.141 | 0.095 | 0.141 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.127 0.109 DBMET01818 | ||
| 0.106 | 0.061 | 0.136 | Beta glucuronidase inhibitor | 0.136 0.033 DBMET01818 | DBMET01818 | |
| 0.093 | 0.05 | 0.094 | ATPase (Vacuolar H+) inhibitor | 0.094 0.049 DBMET01818 | DBMET01818 | |
| 0.054 | 0.013 | 0.057 | Nicotinic acid receptor 2 agonist | 0.057 0.012 DBMET01818 | DBMET01818 | |
| 0.088 | 0.049 | 0.088 | 3C-Like protease (SARS coronavirus) inhibitor | 0.085 0.055 DBMET01818 | ||
| 0.067 | 0.028 | 0.067 | Prostaglandin antagonist | 0.046 0.043 DBMET01818 | ||
| 0.136 | 0.099 | 0.155 | Interferon gamma antagonist | 0.155 0.072 DBMET01818 | DBMET01818 | |
| 0.082 | 0.046 | 0.082 | Catalase inhibitor | |||
| 0.048 | 0.017 | 0.048 | TRPM8 blocker | |||
| 0.191 | 0.162 | 0.191 | Gastrin inhibitor | |||
| 0.123 | 0.095 | 0.126 | Cell wall synthesis inhibitor | 0.126 0.091 DBMET01818 | DBMET01818 | |
| 0.131 | 0.102 | 0.138 | Hexokinase inhibitor | 0.138 0.094 DBMET01818 | DBMET01818 | |
| 0.13 | 0.101 | 0.138 | Phospholipase A2 inhibitor | 0.138 0.089 DBMET01818 | DBMET01818 | |
| 0.084 | 0.058 | 0.097 | D-Ala-D-Ala ligase inhibitor | 0.097 0.033 DBMET01818 | DBMET01818 | |
| 0.12 | 0.094 | 0.12 | Neurotrophic factor | 0.119 0.096 DBMET01818 | ||
| 0.124 | 0.099 | 0.124 | Death-associated protein kinase 1 inhibitor | |||
| 0.033 | 0.009 | 0.033 | Nicotinic acid receptor 2 antagonist | 0.027 0.018 DBMET01818 | ||
| 0.111 | 0.087 | 0.111 | M17 leucyl aminopeptidase inhibitor | 0.108 0.091 DBMET01818 | ||
| 0.039 | 0.016 | 0.039 | HMG CoA reductase inhibitor | 0.037 0.019 DBMET01818 | ||
| 0.058 | 0.035 | 0.058 | Leukotriene C antagonist | 0.058 0.034 DBMET01818 | ||
| 0.273 | 0.251 | 0.273 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.192 | 0.17 | 0.2 | Insulysin inhibitor | 0.2 0.157 DBMET01818 | DBMET01818 | |
| 0.035 | 0.013 | 0.035 | Leukotriene D4 antagonist | 0.032 0.014 DBMET01818 | ||
| 0.096 | 0.075 | 0.112 | Mediator release inhibitor | 0.112 0.056 DBMET01818 | DBMET01818 | |
| 0.048 | 0.027 | 0.048 | Dihydroorotase inhibitor | |||
| 0.036 | 0.016 | 0.036 | Prostaglandin EP3 antagonist | 0.029 0.022 DBMET01818 | ||
| 0.033 | 0.013 | 0.033 | LFA antagonist | |||
| 0.108 | 0.091 | 0.108 | Alpha-N-acetylglucosaminidase inhibitor | |||
| 0.083 | 0.066 | 0.09 | Interleukin 5 antagonist | 0.09 0.055 DBMET01818 | DBMET01818 | |
| 0.142 | 0.125 | 0.165 | DNA methylase inhibitor | 0.165 0.105 DBMET01818 | DBMET01818 | |
| 0.051 | 0.036 | 0.051 | Factor IXa inhibitor | 0.049 0.039 DBMET01818 | ||
| 0.048 | 0.034 | 0.048 | CC chemokine receptor 2B antagonist | 0.046 0.04 DBMET01818 | ||
| 0.025 | 0.011 | 0.025 | Kainate receptor 5 antagonist | |||
| 0.025 | 0.011 | 0.025 | Prostaglandin EP1 antagonist | 0.018 0.015 DBMET01818 | ||
| 0.134 | 0.121 | 0.153 | Amyloid beta precursor protein antagonist | 0.153 0.098 DBMET01818 | DBMET01818 | |
| 0.083 | 0.071 | 0.083 | Potassium channel activator | |||
| 0.095 | 0.083 | 0.151 | Cystathionine beta-synthase inhibitor | 0.151 0.04 DBMET01818 | DBMET01818 | |
| 0.027 | 0.015 | 0.027 | Kainate receptor 4 antagonist | |||
| 0.036 | 0.026 | 0.036 | Inosine monophosphate dehydrogenase inhibitor | 0.034 0.028 DBMET01818 | ||
| 0.026 | 0.017 | 0.026 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.032 | 0.023 | 0.032 | Histone deacetylase 5 inhibitor | |||
| 0.053 | 0.045 | 0.059 | Adenine nucleotide translocase inhibitor | 0.059 0.031 DBMET01818 | DBMET01818 | |
| 0.088 | 0.081 | 0.088 | GABA C receptor agonist | |||
| 0.038 | 0.031 | 0.038 | Leukotriene C4 antagonist | 0.037 0.032 DBMET01818 | ||
| 0.138 | 0.134 | 0.158 | Neurotensin receptor agonist | 0.158 0.084 DBMET01818 | DBMET01818 | |
| 0.057 | 0.052 | 0.057 | Prostaglandin F2 alpha antagonist | |||
| 0.084 | 0.082 | 0.084 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.129 | 0.127 | 0.129 | Ca2+-transporting ATPase inhibitor | |||
| 0.036 | 0.035 | 0.036 | Retinoic acid alpha receptor agonist | |||
| 0.088 | 0.088 | 0.107 | Carbonic anhydrase XV inhibitor | 0.107 0.058 DBMET01818 | DBMET01818 | |
| 0.118 | 0.118 | 0.128 | Sigma receptor agonist | 0.128 0.104 DBMET01818 | DBMET01818 | |
| 0.202 | 0.205 | 0.239 | GABA C receptor rho-3 antagonist | 0.239 0.165 DBMET01818 | DBMET01818 | |
| 0.087 | 0.091 | 0.105 | AMP-activated protein kinase stimulant | 0.105 0.064 DBMET01818 | DBMET01818 | |
| 0.056 | 0.064 | 0.063 | Neuraminidase (influenza) inhibitor | 0.063 0.046 DBMET01818 | DBMET01818 | |
| 0.143 | 0.151 | 0.155 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.155 0.137 DBMET01818 | DBMET01818 | |
| 0.094 | 0.102 | 0.157 | Amylase inhibitor | 0.157 0.061 DBMET01818 | DBMET01818 | |
| 0.115 | 0.124 | 0.151 | NOS3 expression enhancer | 0.151 0.072 DBMET01818 | DBMET01818 | |
| 0.085 | 0.096 | 0.103 | Protein-tyrosine phosphatase 1B inhibitor | 0.103 0.075 DBMET01818 | DBMET01818 | |
| 0.101 | 0.115 | 0.127 | Alkaline phosphatase inhibitor | 0.127 0.079 DBMET01818 | DBMET01818 | |
| 0.079 | 0.094 | 0.112 | Carbonic anhydrase III inhibitor | 0.112 0.051 DBMET01818 | DBMET01818 | |
| 0.151 | 0.171 | 0.194 | Streptokinase A inhibitor | 0.194 0.137 DBMET01818 | DBMET01818 | |
| 0.047 | 0.069 | 0.066 | HIV-1 integrase (3'-Processing) inhibitor | 0.066 0.042 DBMET01818 | DBMET01818 | |
| 0.044 | 0.067 | 0.063 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.063 0.037 DBMET01818 | DBMET01818 | |
| 0.2 | 0.225 | 0.223 | DNA polymerase beta inhibitor | 0.223 0.208 DBMET01818 | DBMET01818 | |
| 0.07 | 0.102 | 0.087 | Urease inhibitor | 0.087 0.081 DBMET01818 | DBMET01818 | |
| 0.115 | 0.148 | 0.135 | Dual specificity phosphatase inhibitor | 0.135 0.112 DBMET01818 | DBMET01818 | |
| 0.075 | 0.117 | 0.093 | Interleukin 12 antagonist | 0.093 0.066 DBMET01818 | DBMET01818 | |
| 0.058 | 0.101 | 0.077 | Carbonic anhydrase VI inhibitor | 0.077 0.061 DBMET01818 | DBMET01818 | |
| 0.127 | 0.182 | 0.221 | Free radical scavenger | 0.221 0.083 DBMET01818 | DBMET01818 | |
| 0.065 | 0.146 | 0.113 | M18 aspartyl aminopeptidase inhibitor | 0.113 0.077 DBMET01818 | DBMET01818 | |
| 0.079 | 0.166 | 0.123 | Interleukin 4 antagonist | 0.123 0.081 DBMET01818 | DBMET01818 | |
| 0.047 | 0.136 | 0.106 | Monophenol monooxygenase inhibitor | 0.106 0.072 DBMET01818 | DBMET01818 | |
| 0.08 | 0.171 | 0.127 | Peroxidase inhibitor | 0.127 0.093 DBMET01818 | DBMET01818 | |
| 0.087 | 0.178 | 0.158 | Amyloid beta aggregation inhibitor | 0.158 0.102 DBMET01818 | DBMET01818 | |
| 0.091 | 0.187 | 0.133 | Pyruvate kinase inhibitor | 0.133 0.132 DBMET01818 | DBMET01818 | |
| 0.097 | 0.194 | 0.139 | Interleukin antagonist | 0.139 0.126 DBMET01818 | DBMET01818 | |
| 0.117 | 0.217 | 0.209 | Antioxidant | 0.209 0.108 DBMET01818 | DBMET01818 | |
| 0.139 | 0.239 | 0.214 | Transcription factor NF kappa B inhibitor | 0.214 0.156 DBMET01818 | DBMET01818 | |
| 0.046 | 0.316 | 0.114 | Estrogen antagonist | 0.114 0.067 DBMET01818 | DBMET01818 | |
| 0.026 | 0.401 | 0.094 | Estrogen receptor beta antagonist | 0.094 0.075 DBMET01818 | DBMET01818 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |